Back to Search
CAMRI J MCGINN M.D.
M.D.
Family Medicine Physician
NPI: 1285011684IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
0058324(CO)
Education
UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Class of 2015
Research & Publications (20)
Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials.
PMID 12826246·Int J Radiat Oncol Biol Phys·2003
6-review
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
PMID 12209674·Cancer·2002
6-review
Recent advances in the use of radiosensitizing nucleosides.
PMID 11677652·Semin Radiat Oncol·2001
6-review
Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.
PMID 11709563·J Clin Oncol·2001
3-trial
The role of radiation therapy in resectable retroperitoneal sarcomas.
PMID 11094324·Surg Oncol·2000
5-case
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
PMID 18281668·J Clin Oncol·2008
3-trial
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
PMID 17762432·Am J Clin Oncol·2007
3-trial
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.
PMID 17560050·Int J Radiat Oncol Biol Phys·2007
8-other
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
PMID 16418882·Ann Surg Oncol·2006
3-trial
Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
PMID 15993549·Int J Radiat Oncol Biol Phys·2005
8-other
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
PMID 15625365·J Clin Oncol·2005
3-trial
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
PMID 15234045·Int J Radiat Oncol Biol Phys·2004
3-trial
Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer.
PMID 14665608·J Clin Oncol·2004
3-trial
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
PMID 15275733·Int J Radiat Oncol Biol Phys·2004
3-trial
The mechanism of action of radiosensitization of conventional chemotherapeutic agents.
PMID 12520460·Semin Radiat Oncol·2003
6-review
Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.
PMID 14679011·Cancer Res·2003
7-preclinical
Conformal chemoradiation for primary and metastatic liver malignancies.
PMID 14648782·Semin Surg Oncol·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1960 N OGDEN ST STE 490
DENVER, CO 80218 - Phone
- (303) 318-3202
Quick Facts
- NPI
- 1285011684
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile